Dementia is a clinical syndrome that is characterized by impairment of cognitive and functional abilities (daily
life activities) as well as by neuropsychiatric symptoms. Cognitive impairment can include impairment of memory,
visuospatial functions, language, and executive functions. Many neurodegenerative diseases turn over to dementia,
Alzheimer´s Disease being the most frequent of them. Alzheimer´s Disease (AD) affect a large population worldwide.
In the last decade, various medications have been used for the treatment of cognitive symptoms in AD. Many of them
have few scientific evidence of their effectiveness. The aim of this paper is to review and update the current status of the
pharmacological treatment of cognitive symptoms in Alzheimer´s Disease.